Literature DB >> 31119718

Abnormal elastin and collagen deposition is present in extracranial arteriovenous malformations: A comparison to intracranial disease.

Ting Wei1, Sara Shalin2, Elizabeth Draper3, Emily Miller4, Haihong Zhang5, Ravi Sun5, Madison Lee5, Gregory Albert6, Gresham T Richter5,7.   

Abstract

BACKGROUND: Vascular malformations are characterized by anomalous vascular channels with fragile walls and a propensity to bleed. Arteriovenous malformations (AVMs) in particular have disorganized vascular spaces with intervening fibrosis. Characterization of the structural abnormalities of these vessels has not been comprehensively evaluated. We hypothesize that AVMs are likely to demonstrate altered elastic and collagen fiber organization and distribution, reflecting their fragility, vascular instability, and abnormal development.
METHODS: Fifteen AVMs were histologically evaluated by H&E, elastin and trichrome staining. To identify potential differences between extracranial and intracranial AVMs, 5 AVMs were harvested from the brain (n=5) and 10 from extracranial sites involving the skin and deep soft tissue (n=10).
RESULTS: The elastin staining demonstrated reduplication, fragmentation and disruption of internal elastic lamina as well as irregular thickness, and inconsistent vascular density of all AVM specimens. Trichrome staining revealed thickening of the intimal layers of AVM arteries and demonstrated an irregular thickness of venous walls within the malformation and some areas of medial degeneration. Intracranial AVMs are characterized by more intramural inflammation with predominant neutrophil and lymphocyte infiltration. In contrast, extracranial AVMs display more extravascular inflammation with mast cell and neutrophil infiltration. Microvascular proliferations intervening between larger blood vessels were also noted in both types of AVMs, but more obvious in extracranial AVMs.
CONCLUSION: These observed histologic anomalies of AVMs demonstrate disorganized deposition of elastin and collagen that point to the clinically observed vascular instability and fragility of these lesions.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31119718     DOI: 10.14670/HH-18-129

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  3 in total

1.  Clinical Outcome and Quality of Life of Multimodal Treatment of Extracranial Arteriovenous Malformations: The APOLLON Study Protocol.

Authors:  Vanessa F Schmidt; Max Masthoff; Veronika Vielsmeier; Caroline T Seebauer; Özlem Cangir; Lutz Meyer; Antje Mükke; Werner Lang; Axel Schmid; Peter B Sporns; Richard Brill; Walter A Wohlgemuth; Natascha Platz Batista da Silva; Max Seidensticker; Regina Schinner; Julia Küppers; Beate Häberle; Frank Haubner; Jens Ricke; Martin Zenker; Melanie A Kimm; Moritz Wildgruber
Journal:  Cardiovasc Intervent Radiol       Date:  2022-10-19       Impact factor: 2.797

2.  Evidence for endothelial-to-mesenchymal transition in human brain arteriovenous malformations.

Authors:  Lorelei D Shoemaker; Aaron K McCormick; Breanna M Allen; Steven D Chang
Journal:  Clin Transl Med       Date:  2020-06-21

3.  Extracranial arteriovenous malformations demonstrate dysregulated TGF-β/BMP signaling and increased circulating TGF-β1.

Authors:  Ting Wei; Gresham T Richter; Haihong Zhang; Ravi W Sun; Conor H Smith; Graham M Strub
Journal:  Sci Rep       Date:  2022-10-05       Impact factor: 4.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.